pharmachologic effect

Nootropic agent. Has a positive effect on the metabolic processes and blood circulation of the brain. Increases the utilization of glucose, improves the flow of metabolic processes, improves microcirculation in ischemic zones, inhibits the aggregation of activated platelets. Has a protective effect in brain damage caused by hypoxia, intoxication, electric shock. Improves the integrative activity of the brain. Does not have sedative and psychostimulating effects.

Indications

Memory impairment, dizziness, decreased concentration, emotional lability, dementia due to cerebral circulation (ischemic stroke), cerebral trauma, Alzheimer's disease, old age; comatose state of vascular, traumatic or toxic origin; treatment of abstinence and psycho-organic syndrome in chronic alcoholism; learning disabilities in children, not associated with inadequate training or family situation (as part of combination therapy); sickle cell anemia (in combination therapy).